Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Devy Zisman

Showing results (61-70 of 80) with videos related to

Pageof 8
Sort By:
Clinical Rheumatology|December 11, 2023
The risk factors for uveitis among psoriatic arthritis patients: a population-based cohort studyNizar Hijazi, Tal Gazitt, Amir Haddad, et al.
Frontiers in Immunology|February 6, 2024
Soluble CD147 regulates endostatin via its effects on the activities of MMP-9 and secreted proteasome 20SMaya M Rahat, Hala Sabtan, Elina Simanovich, et al.
European Journal of Rheumatology|July 23, 2019
Treat-to-target concept implementation for evaluating rheumatoid arthritis patients in daily practiceTal Gazitt, Shirley Oren, Tatiana Reitblat, et al.
Frontiers in Immunology|January 3, 2022
Tocilizumab (TCZ) Decreases Angiogenesis in Rheumatoid Arthritis Through Its Regulatory Effect on miR-146a-5p and EMMPRIN/CD147Devy Zisman, Mirna Safieh, Elina Simanovich, et al.
JAMA Dermatology|March 24, 2015
Systemic Therapy for Psoriasis and the Risk of Herpes Zoster: A 500,000 Person-year StudyGuy Shalom, Devy Zisman, Haim Bitterman, et al.
Arthritis Research & Therapy|April 11, 2025
Achievement of treatment targets and maintenance of response with upadacitinib in patients with moderate-to-severe rheumatoid arthritis in real-world practice: 1-year outcomes from the UPHOLD observational studyAndrew Östör, Eugen Feist, Prodromos Sidiropoulos, et al.
Vaccine|November 27, 2019
Immunogenicity and safety of vaccination against seasonal influenza vaccine in patients with psoriatic arthritis treated with secukinumabVictoria Furer, Devy Zisman, Ilana Kaufman, et al.
Clinical Rheumatology|March 2, 2011
Recently diagnosed axial spondyloarthritis: gender differences and factors related to delay in diagnosisGleb Slobodin, Iris Reyhan, Nina Avshovich, et al.
The Journal of Rheumatology|November 17, 2014
Prevalence of TNF-α blocker immunogenicity in psoriatic arthritisMichael Zisapel, Devy Zisman, Noa Madar-Balakirski, et al.
Vaccines|February 28, 2023
Development of Autoantibodies Following BNT162b2 mRNA COVID-19 Vaccination and Their Association with Disease Flares in Adult Patients with Autoimmune Inflammatory Rheumatic Diseases (AIIRD) and the General Population: Results of 1-Year Prospective Follow-Up StudyTal Gazitt, Tali Eviatar, Jacqueline Shear, et al.
Pageof 8

Showing results (61-70 of 80) with videos related to

Sort By:
Pageof 8
Clinical Rheumatology|December 11, 2023
The risk factors for uveitis among psoriatic arthritis patients: a population-based cohort studyNizar Hijazi, Tal Gazitt, Amir Haddad, et al.
Frontiers in Immunology|February 6, 2024
Soluble CD147 regulates endostatin via its effects on the activities of MMP-9 and secreted proteasome 20SMaya M Rahat, Hala Sabtan, Elina Simanovich, et al.
European Journal of Rheumatology|July 23, 2019
Treat-to-target concept implementation for evaluating rheumatoid arthritis patients in daily practiceTal Gazitt, Shirley Oren, Tatiana Reitblat, et al.
Frontiers in Immunology|January 3, 2022
Tocilizumab (TCZ) Decreases Angiogenesis in Rheumatoid Arthritis Through Its Regulatory Effect on miR-146a-5p and EMMPRIN/CD147Devy Zisman, Mirna Safieh, Elina Simanovich, et al.
JAMA Dermatology|March 24, 2015
Systemic Therapy for Psoriasis and the Risk of Herpes Zoster: A 500,000 Person-year StudyGuy Shalom, Devy Zisman, Haim Bitterman, et al.
Arthritis Research & Therapy|April 11, 2025
Achievement of treatment targets and maintenance of response with upadacitinib in patients with moderate-to-severe rheumatoid arthritis in real-world practice: 1-year outcomes from the UPHOLD observational studyAndrew Östör, Eugen Feist, Prodromos Sidiropoulos, et al.
Vaccine|November 27, 2019
Immunogenicity and safety of vaccination against seasonal influenza vaccine in patients with psoriatic arthritis treated with secukinumabVictoria Furer, Devy Zisman, Ilana Kaufman, et al.
Clinical Rheumatology|March 2, 2011
Recently diagnosed axial spondyloarthritis: gender differences and factors related to delay in diagnosisGleb Slobodin, Iris Reyhan, Nina Avshovich, et al.
The Journal of Rheumatology|November 17, 2014
Prevalence of TNF-α blocker immunogenicity in psoriatic arthritisMichael Zisapel, Devy Zisman, Noa Madar-Balakirski, et al.
Vaccines|February 28, 2023
Development of Autoantibodies Following BNT162b2 mRNA COVID-19 Vaccination and Their Association with Disease Flares in Adult Patients with Autoimmune Inflammatory Rheumatic Diseases (AIIRD) and the General Population: Results of 1-Year Prospective Follow-Up StudyTal Gazitt, Tali Eviatar, Jacqueline Shear, et al.
Pageof 8